CareDx, Inc. develops diagnostic and monitoring solutions for transplant recipients in the United States and internationally. The company's offerings include blood tests that detect donor-derived DNA to monitor kidney, heart, and lung transplant patients; gene expression tests for heart transplant monitoring; tissue analysis tools for kidney biopsy evaluation; and HLA typing solutions for transplant compatibility assessment. Additionally, CareDx provides transplant management software platforms, tests for monitoring cell therapy treatments, and a test for predicting relapse in certain blood cancers.
1Y: 87.41 (+482.7%) · range 14.52–87.41
entry readiness 0 · NOT READY · exit proximity 90
Value area 35.29–73.77 · 1% of 120d volume overhead · clean runway
| Source | Score | Last seen |
|---|---|---|
| trend-signal | 1.000 | Oct 30, 2026 |
| Horizon | Return | MFE | State |
|---|---|---|---|
| 20d | +6.99% | +9.35% | 7/20d |
| 40d | +6.99% | +9.35% | 7/40d |